Global Immunology Drug Market Insights and Forecast to 2026


Immunology Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Immunology Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Immunology Drug market is segmented into
    Monoclonal Antibodies (mAb)
    Antibody Drug Conjugates
    Interferon and Cytokine therapies
    Immunosuppressive medication

Segment by Application, the Immunology Drug market is segmented into
    Hospitals
    Clinics
    Cancer Research Centers and Institutes

Regional and Country-level Analysis
The Immunology Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Immunology Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Immunology Drug Market Share Analysis
Immunology Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Immunology Drug business, the date to enter into the Immunology Drug market, Immunology Drug product introduction, recent developments, etc.

The major vendors covered:
    Abbott Laboratories
    Active Biotech
    Eli Lilly and Company
    Autoimmune Inc.
    Pfizer
    GlaxoSmithKline plc
    Seattle Genetics
    Genentech
    F. Hoffmann-La Roche Ltd.
    Eisai Co.
    Bayer AG
    Sanofi Aventis LLC.
1 Study Coverage
    1.1 Immunology Drug Product Introduction
    1.2 Market Segments
    1.3 Key Immunology Drug Manufacturers Covered: Ranking by Revenue
    1.4 Market by Type
        1.4.1 Global Immunology Drug Market Size Growth Rate by Type
        1.4.2 Monoclonal Antibodies (mAb)
        1.4.3 Antibody Drug Conjugates
        1.4.4 Interferon and Cytokine therapies
        1.4.5 Immunosuppressive medication
    1.5 Market by Application
        1.5.1 Global Immunology Drug Market Size Growth Rate by Application
        1.5.2 Hospitals
        1.5.3 Clinics
        1.5.4 Cancer Research Centers and Institutes
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Immunology Drug Market Size, Estimates and Forecasts
        2.1.1 Global Immunology Drug Revenue 2015-2026
        2.1.2 Global Immunology Drug Sales 2015-2026
    2.2 Global Immunology Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
        2.2.1 Global Immunology Drug Retrospective Market Scenario in Sales by Region: 2015-2020
        2.2.2 Global Immunology Drug Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Immunology Drug Competitor Landscape by Players
    3.1 Immunology Drug Sales by Manufacturers
        3.1.1 Immunology Drug Sales by Manufacturers (2015-2020)
        3.1.2 Immunology Drug Sales Market Share by Manufacturers (2015-2020)
    3.2 Immunology Drug Revenue by Manufacturers
        3.2.1 Immunology Drug Revenue by Manufacturers (2015-2020)
        3.2.2 Immunology Drug Revenue Share by Manufacturers (2015-2020)
        3.2.3 Global Immunology Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
        3.2.4 Global Top 10 and Top 5 Companies by Immunology Drug Revenue in 2019
        3.2.5 Global Immunology Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Immunology Drug Price by Manufacturers
    3.4 Immunology Drug Manufacturing Base Distribution, Product Types
        3.4.1 Immunology Drug Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Immunology Drug Product Type
        3.4.3 Date of International Manufacturers Enter into Immunology Drug Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
    4.1 Global Immunology Drug Market Size by Type (2015-2020)
        4.1.1 Global Immunology Drug Sales by Type (2015-2020)
        4.1.2 Global Immunology Drug Revenue by Type (2015-2020)
        4.1.3 Immunology Drug Average Selling Price (ASP) by Type (2015-2026)
    4.2 Global Immunology Drug Market Size Forecast by Type (2021-2026)
        4.2.1 Global Immunology Drug Sales Forecast by Type (2021-2026)
        4.2.2 Global Immunology Drug Revenue Forecast by Type (2021-2026)
        4.2.3 Immunology Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
    4.3 Global Immunology Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
    5.1 Global Immunology Drug Market Size by Application (2015-2020)
        5.1.1 Global Immunology Drug Sales by Application (2015-2020)
        5.1.2 Global Immunology Drug Revenue by Application (2015-2020)
        5.1.3 Immunology Drug Price by Application (2015-2020)
    5.2 Immunology Drug Market Size Forecast by Application (2021-2026)
        5.2.1 Global Immunology Drug Sales Forecast by Application (2021-2026)
        5.2.2 Global Immunology Drug Revenue Forecast by Application (2021-2026)
        5.2.3 Global Immunology Drug Price Forecast by Application (2021-2026)

6 North America
    6.1 North America Immunology Drug by Country
        6.1.1 North America Immunology Drug Sales by Country
        6.1.2 North America Immunology Drug Revenue by Country
        6.1.3 U.S.
        6.1.4 Canada
    6.2 North America Immunology Drug Market Facts & Figures by Type
    6.3 North America Immunology Drug Market Facts & Figures by Application

7 Europe
    7.1 Europe Immunology Drug by Country
        7.1.1 Europe Immunology Drug Sales by Country
        7.1.2 Europe Immunology Drug Revenue by Country
        7.1.3 Germany
        7.1.4 France
        7.1.5 U.K.
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Immunology Drug Market Facts & Figures by Type
    7.3 Europe Immunology Drug Market Facts & Figures by Application

8 Asia Pacific
    8.1 Asia Pacific Immunology Drug by Region
        8.1.1 Asia Pacific Immunology Drug Sales by Region
        8.1.2 Asia Pacific Immunology Drug Revenue by Region
        8.1.3 China
        8.1.4 Japan
        8.1.5 South Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Taiwan
        8.1.9 Indonesia
        8.1.10 Thailand
        8.1.11 Malaysia
        8.1.12 Philippines
        8.1.13 Vietnam
    8.2 Asia Pacific Immunology Drug Market Facts & Figures by Type
    8.3 Asia Pacific Immunology Drug Market Facts & Figures by Application

9 Latin America
    9.1 Latin America Immunology Drug by Country
        9.1.1 Latin America Immunology Drug Sales by Country
        9.1.2 Latin America Immunology Drug Revenue by Country
        9.1.3 Mexico
        9.1.4 Brazil
        9.1.5 Argentina
    9.2 Central & South America Immunology Drug Market Facts & Figures by Type
    9.3 Central & South America Immunology Drug Market Facts & Figures by Application

10 Middle East and Africa
    10.1 Middle East and Africa Immunology Drug by Country
        10.1.1 Middle East and Africa Immunology Drug Sales by Country
        10.1.2 Middle East and Africa Immunology Drug Revenue by Country
        10.1.3 Turkey
        10.1.4 Saudi Arabia
        10.1.5 U.A.E
    10.2 Middle East and Africa Immunology Drug Market Facts & Figures by Type
    10.3 Middle East and Africa Immunology Drug Market Facts & Figures by Application

11 Company Profiles
    11.1 Abbott Laboratories
        11.1.1 Abbott Laboratories Corporation Information
        11.1.2 Abbott Laboratories Description and Business Overview
        11.1.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
        11.1.4 Abbott Laboratories Immunology Drug Products Offered
        11.1.5 Abbott Laboratories Related Developments
    11.2 Active Biotech
        11.2.1 Active Biotech Corporation Information
        11.2.2 Active Biotech Description and Business Overview
        11.2.3 Active Biotech Sales, Revenue and Gross Margin (2015-2020)
        11.2.4 Active Biotech Immunology Drug Products Offered
        11.2.5 Active Biotech Related Developments
    11.3 Eli Lilly and Company
        11.3.1 Eli Lilly and Company Corporation Information
        11.3.2 Eli Lilly and Company Description and Business Overview
        11.3.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
        11.3.4 Eli Lilly and Company Immunology Drug Products Offered
        11.3.5 Eli Lilly and Company Related Developments
    11.4 Autoimmune Inc.
        11.4.1 Autoimmune Inc. Corporation Information
        11.4.2 Autoimmune Inc. Description and Business Overview
        11.4.3 Autoimmune Inc. Sales, Revenue and Gross Margin (2015-2020)
        11.4.4 Autoimmune Inc. Immunology Drug Products Offered
        11.4.5 Autoimmune Inc. Related Developments
    11.5 Pfizer
        11.5.1 Pfizer Corporation Information
        11.5.2 Pfizer Description and Business Overview
        11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
        11.5.4 Pfizer Immunology Drug Products Offered
        11.5.5 Pfizer Related Developments
    11.6 GlaxoSmithKline plc
        11.6.1 GlaxoSmithKline plc Corporation Information
        11.6.2 GlaxoSmithKline plc Description and Business Overview
        11.6.3 GlaxoSmithKline plc Sales, Revenue and Gross Margin (2015-2020)
        11.6.4 GlaxoSmithKline plc Immunology Drug Products Offered
        11.6.5 GlaxoSmithKline plc Related Developments
    11.7 Seattle Genetics
        11.7.1 Seattle Genetics Corporation Information
        11.7.2 Seattle Genetics Description and Business Overview
        11.7.3 Seattle Genetics Sales, Revenue and Gross Margin (2015-2020)
        11.7.4 Seattle Genetics Immunology Drug Products Offered
        11.7.5 Seattle Genetics Related Developments
    11.8 Genentech
        11.8.1 Genentech Corporation Information
        11.8.2 Genentech Description and Business Overview
        11.8.3 Genentech Sales, Revenue and Gross Margin (2015-2020)
        11.8.4 Genentech Immunology Drug Products Offered
        11.8.5 Genentech Related Developments
    11.9 F. Hoffmann-La Roche Ltd.
        11.9.1 F. Hoffmann-La Roche Ltd. Corporation Information
        11.9.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
        11.9.3 F. Hoffmann-La Roche Ltd. Sales, Revenue and Gross Margin (2015-2020)
        11.9.4 F. Hoffmann-La Roche Ltd. Immunology Drug Products Offered
        11.9.5 F. Hoffmann-La Roche Ltd. Related Developments
    11.10 Eisai Co.
        11.10.1 Eisai Co. Corporation Information
        11.10.2 Eisai Co. Description and Business Overview
        11.10.3 Eisai Co. Sales, Revenue and Gross Margin (2015-2020)
        11.10.4 Eisai Co. Immunology Drug Products Offered
        11.10.5 Eisai Co. Related Developments
    11.1 Abbott Laboratories
        11.1.1 Abbott Laboratories Corporation Information
        11.1.2 Abbott Laboratories Description and Business Overview
        11.1.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
        11.1.4 Abbott Laboratories Immunology Drug Products Offered
        11.1.5 Abbott Laboratories Related Developments
    11.12 Sanofi Aventis LLC.
        11.12.1 Sanofi Aventis LLC. Corporation Information
        11.12.2 Sanofi Aventis LLC. Description and Business Overview
        11.12.3 Sanofi Aventis LLC. Sales, Revenue and Gross Margin (2015-2020)
        11.12.4 Sanofi Aventis LLC. Products Offered
        11.12.5 Sanofi Aventis LLC. Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
    12.1 Immunology Drug Market Estimates and Projections by Region
        12.1.1 Global Immunology Drug Sales Forecast by Regions 2021-2026
        12.1.2 Global Immunology Drug Revenue Forecast by Regions 2021-2026
    12.2 North America Immunology Drug Market Size Forecast (2021-2026)
        12.2.1 North America: Immunology Drug Sales Forecast (2021-2026)
        12.2.2 North America: Immunology Drug Revenue Forecast (2021-2026)
        12.2.3 North America: Immunology Drug Market Size Forecast by Country (2021-2026)
    12.3 Europe Immunology Drug Market Size Forecast (2021-2026)
        12.3.1 Europe: Immunology Drug Sales Forecast (2021-2026)
        12.3.2 Europe: Immunology Drug Revenue Forecast (2021-2026)
        12.3.3 Europe: Immunology Drug Market Size Forecast by Country (2021-2026)
    12.4 Asia Pacific Immunology Drug Market Size Forecast (2021-2026)
        12.4.1 Asia Pacific: Immunology Drug Sales Forecast (2021-2026)
        12.4.2 Asia Pacific: Immunology Drug Revenue Forecast (2021-2026)
        12.4.3 Asia Pacific: Immunology Drug Market Size Forecast by Region (2021-2026)
    12.5 Latin America Immunology Drug Market Size Forecast (2021-2026)
        12.5.1 Latin America: Immunology Drug Sales Forecast (2021-2026)
        12.5.2 Latin America: Immunology Drug Revenue Forecast (2021-2026)
        12.5.3 Latin America: Immunology Drug Market Size Forecast by Country (2021-2026)
    12.6 Middle East and Africa Immunology Drug Market Size Forecast (2021-2026)
        12.6.1 Middle East and Africa: Immunology Drug Sales Forecast (2021-2026)
        12.6.2 Middle East and Africa: Immunology Drug Revenue Forecast (2021-2026)
        12.6.3 Middle East and Africa: Immunology Drug Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Market Opportunities and Drivers
    13.2 Market Challenges
    13.3 Market Risks/Restraints
    13.4 Porter's Five Forces Analysis
    13.5 Primary Interviews with Key Immunology Drug Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Immunology Drug Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer

List of Tables Table 1. Immunology Drug Market Segments Table 2. Ranking of Global Top Immunology Drug Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global Immunology Drug Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million) Table 4. Major Manufacturers of Monoclonal Antibodies (mAb) Table 5. Major Manufacturers of Antibody Drug Conjugates Table 6. Major Manufacturers of Interferon and Cytokine therapies Table 7. Major Manufacturers of Immunosuppressive medication Table 8. Global Immunology Drug Market Size Growth Rate by Application 2020-2026 (MT) Table 9. Global Immunology Drug Market Size by Region (MT) & (US$ Million): 2020 VS 2026 Table 10. Global Immunology Drug Sales by Regions 2015-2020 (MT) Table 11. Global Immunology Drug Sales Market Share by Regions (2015-2020) Table 12. Global Immunology Drug Revenue by Regions 2015-2020 (US$ Million) Table 13. Global Immunology Drug Sales by Manufacturers (2015-2020) (MT) Table 14. Global Immunology Drug Sales Share by Manufacturers (2015-2020) Table 15. Global Immunology Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020) Table 16. Global Immunology Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immunology Drug as of 2019) Table 17. Immunology Drug Revenue by Manufacturers (2015-2020) (US$ Million) Table 18. Immunology Drug Revenue Share by Manufacturers (2015-2020) Table 19. Key Manufacturers Immunology Drug Price (2015-2020) (USD/Kg) Table 20. Immunology Drug Manufacturers Manufacturing Base Distribution and Headquarters Table 21. Manufacturers Immunology Drug Product Type Table 22. Date of International Manufacturers Enter into Immunology Drug Market Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans Table 24. Global Immunology Drug Sales by Type (2015-2020) (MT) Table 25. Global Immunology Drug Sales Share by Type (2015-2020) Table 26. Global Immunology Drug Revenue by Type (2015-2020) (US$ Million) Table 27. Global Immunology Drug Revenue Share by Type (2015-2020) Table 28. Immunology Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Kg) Table 29. Global Immunology Drug Sales by Application (2015-2020) (MT) Table 30. Global Immunology Drug Sales Share by Application (2015-2020) Table 31. North America Immunology Drug Sales by Country (2015-2020) (MT) Table 32. North America Immunology Drug Sales Market Share by Country (2015-2020) Table 33. North America Immunology Drug Revenue by Country (2015-2020) (US$ Million) Table 34. North America Immunology Drug Revenue Market Share by Country (2015-2020) Table 35. North America Immunology Drug Sales by Type (2015-2020) (MT) Table 36. North America Immunology Drug Sales Market Share by Type (2015-2020) Table 37. North America Immunology Drug Sales by Application (2015-2020) (MT) Table 38. North America Immunology Drug Sales Market Share by Application (2015-2020) Table 39. Europe Immunology Drug Sales by Country (2015-2020) (MT) Table 40. Europe Immunology Drug Sales Market Share by Country (2015-2020) Table 41. Europe Immunology Drug Revenue by Country (2015-2020) (US$ Million) Table 42. Europe Immunology Drug Revenue Market Share by Country (2015-2020) Table 43. Europe Immunology Drug Sales by Type (2015-2020) (MT) Table 44. Europe Immunology Drug Sales Market Share by Type (2015-2020) Table 45. Europe Immunology Drug Sales by Application (2015-2020) (MT) Table 46. Europe Immunology Drug Sales Market Share by Application (2015-2020) Table 47. Asia Pacific Immunology Drug Sales by Region (2015-2020) (MT) Table 48. Asia Pacific Immunology Drug Sales Market Share by Region (2015-2020) Table 49. Asia Pacific Immunology Drug Revenue by Region (2015-2020) (US$ Million) Table 50. Asia Pacific Immunology Drug Revenue Market Share by Region (2015-2020) Table 51. Asia Pacific Immunology Drug Sales by Type (2015-2020) (MT) Table 52. Asia Pacific Immunology Drug Sales Market Share by Type (2015-2020) Table 53. Asia Pacific Immunology Drug Sales by Application (2015-2020) (MT) Table 54. Asia Pacific Immunology Drug Sales Market Share by Application (2015-2020) Table 55. Latin America Immunology Drug Sales by Country (2015-2020) (MT) Table 56. Latin America Immunology Drug Sales Market Share by Country (2015-2020) Table 57. Latin Americaa Immunology Drug Revenue by Country (2015-2020) (US$ Million) Table 58. Latin America Immunology Drug Revenue Market Share by Country (2015-2020) Table 59. Latin America Immunology Drug Sales by Type (2015-2020) (MT) Table 60. Latin America Immunology Drug Sales Market Share by Type (2015-2020) Table 61. Latin America Immunology Drug Sales by Application (2015-2020) (MT) Table 62. Latin America Immunology Drug Sales Market Share by Application (2015-2020) Table 63. Middle East and Africa Immunology Drug Sales by Country (2015-2020) (MT) Table 64. Middle East and Africa Immunology Drug Sales Market Share by Country (2015-2020) Table 65. Middle East and Africa Immunology Drug Revenue by Country (2015-2020) (US$ Million) Table 66. Middle East and Africa Immunology Drug Revenue Market Share by Country (2015-2020) Table 67. Middle East and Africa Immunology Drug Sales by Type (2015-2020) (MT) Table 68. Middle East and Africa Immunology Drug Sales Market Share by Type (2015-2020) Table 69. Middle East and Africa Immunology Drug Sales by Application (2015-2020) (MT) Table 70. Middle East and Africa Immunology Drug Sales Market Share by Application (2015-2020) Table 71. Abbott Laboratories Corporation Information Table 72. Abbott Laboratories Description and Major Businesses Table 73. Abbott Laboratories Immunology Drug Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020) Table 74. Abbott Laboratories Product Table 75. Abbott Laboratories Recent Development Table 76. Active Biotech Corporation Information Table 77. Active Biotech Description and Major Businesses Table 78. Active Biotech Immunology Drug Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020) Table 79. Active Biotech Product Table 80. Active Biotech Recent Development Table 81. Eli Lilly and Company Corporation Information Table 82. Eli Lilly and Company Description and Major Businesses Table 83. Eli Lilly and Company Immunology Drug Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020) Table 84. Eli Lilly and Company Product Table 85. Eli Lilly and Company Recent Development Table 86. Autoimmune Inc. Corporation Information Table 87. Autoimmune Inc. Description and Major Businesses Table 88. Autoimmune Inc. Immunology Drug Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020) Table 89. Autoimmune Inc. Product Table 90. Autoimmune Inc. Recent Development Table 91. Pfizer Corporation Information Table 92. Pfizer Description and Major Businesses Table 93. Pfizer Immunology Drug Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020) Table 94. Pfizer Product Table 95. Pfizer Recent Development Table 96. GlaxoSmithKline plc Corporation Information Table 97. GlaxoSmithKline plc Description and Major Businesses Table 98. GlaxoSmithKline plc Immunology Drug Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020) Table 99. GlaxoSmithKline plc Product Table 100. GlaxoSmithKline plc Recent Development Table 101. Seattle Genetics Corporation Information Table 102. Seattle Genetics Description and Major Businesses Table 103. Seattle Genetics Immunology Drug Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020) Table 104. Seattle Genetics Product Table 105. Seattle Genetics Recent Development Table 106. Genentech Corporation Information Table 107. Genentech Description and Major Businesses Table 108. Genentech Immunology Drug Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020) Table 109. Genentech Product Table 110. Genentech Recent Development Table 111. F. Hoffmann-La Roche Ltd. Corporation Information Table 112. F. Hoffmann-La Roche Ltd. Description and Major Businesses Table 113. F. Hoffmann-La Roche Ltd. Immunology Drug Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020) Table 114. F. Hoffmann-La Roche Ltd. Product Table 115. F. Hoffmann-La Roche Ltd. Recent Development Table 116. Eisai Co. Corporation Information Table 117. Eisai Co. Description and Major Businesses Table 118. Eisai Co. Immunology Drug Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020) Table 119. Eisai Co. Product Table 120. Eisai Co. Recent Development Table 121. Bayer AG Corporation Information Table 122. Bayer AG Description and Major Businesses Table 123. Bayer AG Immunology Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020) Table 124. Bayer AG Product Table 125. Bayer AG Recent Development Table 126. Sanofi Aventis LLC. Corporation Information Table 127. Sanofi Aventis LLC. Description and Major Businesses Table 128. Sanofi Aventis LLC. Immunology Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020) Table 129. Sanofi Aventis LLC. Product Table 130. Sanofi Aventis LLC. Recent Development Table 131. Global Immunology Drug Sales Forecast by Regions (2021-2026) (MT) Table 132. Global Immunology Drug Sales Market Share Forecast by Regions (2021-2026) Table 133. Global Immunology Drug Revenue Forecast by Regions (2021-2026) (US$ Million) Table 134. Global Immunology Drug Revenue Market Share Forecast by Regions (2021-2026) Table 135. North America: Immunology Drug Sales Forecast by Country (2021-2026) (MT) Table 136. North America: Immunology Drug Revenue Forecast by Country (2021-2026) (US$ Million) Table 137. Europe: Immunology Drug Sales Forecast by Country (2021-2026) (MT) Table 138. Europe: Immunology Drug Revenue Forecast by Country (2021-2026) (US$ Million) Table 139. Asia Pacific: Immunology Drug Sales Forecast by Region (2021-2026) (MT) Table 140. Asia Pacific: Immunology Drug Revenue Forecast by Region (2021-2026) (US$ Million) Table 141. Latin America: Immunology Drug Sales Forecast by Country (2021-2026) (MT) Table 142. Latin America: Immunology Drug Revenue Forecast by Country (2021-2026) (US$ Million) Table 143. Middle East and Africa: Immunology Drug Sales Forecast by Country (2021-2026) (MT) Table 144. Middle East and Africa: Immunology Drug Revenue Forecast by Country (2021-2026) (US$ Million) Table 145. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 146. Key Challenges Table 147. Market Risks Table 148. Main Points Interviewed from Key Immunology Drug Players Table 149. Immunology Drug Customers List Table 150. Immunology Drug Distributors List Table 151. Research Programs/Design for This Report Table 152. Key Data Information from Secondary Sources Table 153. Key Data Information from Primary Sources List of Figures Figure 1. Immunology Drug Product Picture Figure 2. Global Immunology Drug Sales Market Share by Type in 2020 & 2026 Figure 3. Monoclonal Antibodies (mAb) Product Picture Figure 4. Antibody Drug Conjugates Product Picture Figure 5. Interferon and Cytokine therapies Product Picture Figure 6. Immunosuppressive medication Product Picture Figure 7. Global Immunology Drug Sales Market Share by Application in 2020 & 2026 Figure 8. Hospitals Figure 9. Clinics Figure 10. Cancer Research Centers and Institutes Figure 11. Immunology Drug Report Years Considered Figure 12. Global Immunology Drug Market Size 2015-2026 (US$ Million) Figure 13. Global Immunology Drug Sales 2015-2026 (MT) Figure 14. Global Immunology Drug Market Size Market Share by Region: 2020 Versus 2026 Figure 15. Global Immunology Drug Sales Market Share by Region (2015-2020) Figure 16. Global Immunology Drug Sales Market Share by Region in 2019 Figure 17. Global Immunology Drug Revenue Market Share by Region (2015-2020) Figure 18. Global Immunology Drug Revenue Market Share by Region in 2019 Figure 19. Global Immunology Drug Sales Share by Manufacturer in 2019 Figure 20. The Top 10 and 5 Players Market Share by Immunology Drug Revenue in 2019 Figure 21. Immunology Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 22. Global Immunology Drug Sales Market Share by Type (2015-2020) Figure 23. Global Immunology Drug Sales Market Share by Type in 2019 Figure 24. Global Immunology Drug Revenue Market Share by Type (2015-2020) Figure 25. Global Immunology Drug Revenue Market Share by Type in 2019 Figure 26. Global Immunology Drug Market Share by Price Range (2015-2020) Figure 27. Global Immunology Drug Sales Market Share by Application (2015-2020) Figure 28. Global Immunology Drug Sales Market Share by Application in 2019 Figure 29. Global Immunology Drug Revenue Market Share by Application (2015-2020) Figure 30. Global Immunology Drug Revenue Market Share by Application in 2019 Figure 31. North America Immunology Drug Sales Growth Rate 2015-2020 (MT) Figure 32. North America Immunology Drug Revenue Growth Rate 2015-2020 (US$ Million) Figure 33. North America Immunology Drug Sales Market Share by Country in 2019 Figure 34. North America Immunology Drug Revenue Market Share by Country in 2019 Figure 35. U.S. Immunology Drug Sales Growth Rate (2015-2020) (MT) Figure 36. U.S. Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. Canada Immunology Drug Sales Growth Rate (2015-2020) (MT) Figure 38. Canada Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 39. North America Immunology Drug Market Share by Type in 2019 Figure 40. North America Immunology Drug Market Share by Application in 2019 Figure 41. Europe Immunology Drug Sales Growth Rate 2015-2020 (MT) Figure 42. Europe Immunology Drug Revenue Growth Rate 2015-2020 (US$ Million) Figure 43. Europe Immunology Drug Sales Market Share by Country in 2019 Figure 44. Europe Immunology Drug Revenue Market Share by Country in 2019 Figure 45. Germany Immunology Drug Sales Growth Rate (2015-2020) (MT) Figure 46. Germany Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. France Immunology Drug Sales Growth Rate (2015-2020) (MT) Figure 48. France Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. U.K. Immunology Drug Sales Growth Rate (2015-2020) (MT) Figure 50. U.K. Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. Italy Immunology Drug Sales Growth Rate (2015-2020) (MT) Figure 52. Italy Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Russia Immunology Drug Sales Growth Rate (2015-2020) (MT) Figure 54. Russia Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Europe Immunology Drug Market Share by Type in 2019 Figure 56. Europe Immunology Drug Market Share by Application in 2019 Figure 57. Asia Pacific Immunology Drug Sales Growth Rate 2015-2020 (MT) Figure 58. Asia Pacific Immunology Drug Revenue Growth Rate 2015-2020 (US$ Million) Figure 59. Asia Pacific Immunology Drug Sales Market Share by Region in 2019 Figure 60. Asia Pacific Immunology Drug Revenue Market Share by Region in 2019 Figure 61. China Immunology Drug Sales Growth Rate (2015-2020) (MT) Figure 62. China Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 63. Japan Immunology Drug Sales Growth Rate (2015-2020) (MT) Figure 64. Japan Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 65. South Korea Immunology Drug Sales Growth Rate (2015-2020) (MT) Figure 66. South Korea Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. India Immunology Drug Sales Growth Rate (2015-2020) (MT) Figure 68. India Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Australia Immunology Drug Sales Growth Rate (2015-2020) (MT) Figure 70. Australia Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. Taiwan Immunology Drug Sales Growth Rate (2015-2020) (MT) Figure 72. Taiwan Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Indonesia Immunology Drug Sales Growth Rate (2015-2020) (MT) Figure 74. Indonesia Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. Thailand Immunology Drug Sales Growth Rate (2015-2020) (MT) Figure 76. Thailand Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Malaysia Immunology Drug Sales Growth Rate (2015-2020) (MT) Figure 78. Malaysia Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. Philippines Immunology Drug Sales Growth Rate (2015-2020) (MT) Figure 80. Philippines Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 81. Vietnam Immunology Drug Sales Growth Rate (2015-2020) (MT) Figure 82. Vietnam Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 83. Asia Pacific Immunology Drug Market Share by Type in 2019 Figure 84. Asia Pacific Immunology Drug Market Share by Application in 2019 Figure 85. Latin America Immunology Drug Sales Growth Rate 2015-2020 (MT) Figure 86. Latin America Immunology Drug Revenue Growth Rate 2015-2020 (US$ Million) Figure 87. Latin America Immunology Drug Sales Market Share by Country in 2019 Figure 88. Latin America Immunology Drug Revenue Market Share by Country in 2019 Figure 89. Mexico Immunology Drug Sales Growth Rate (2015-2020) (MT) Figure 90. Mexico Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 91. Brazil Immunology Drug Sales Growth Rate (2015-2020) (MT) Figure 92. Brazil Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 93. Argentina Immunology Drug Sales Growth Rate (2015-2020) (MT) Figure 94. Argentina Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 95. Latin America Immunology Drug Market Share by Type in 2019 Figure 96. Latin America Immunology Drug Market Share by Application in 2019 Figure 97. Middle East and Africa Immunology Drug Sales Growth Rate 2015-2020 (MT) Figure 98. Middle East and Africa Immunology Drug Revenue Growth Rate 2015-2020 (US$ Million) Figure 99. Middle East and Africa Immunology Drug Sales Market Share by Country in 2019 Figure 100. Middle East and Africa Immunology Drug Revenue Market Share by Country in 2019 Figure 101. Turkey Immunology Drug Sales Growth Rate (2015-2020) (MT) Figure 102. Turkey Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 103. Saudi Arabia Immunology Drug Sales Growth Rate (2015-2020) (MT) Figure 104. Saudi Arabia Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 105. U.A.E Immunology Drug Sales Growth Rate (2015-2020) (MT) Figure 106. U.A.E Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 107. Middle East and Africa Immunology Drug Market Share by Type in 2019 Figure 108. Middle East and Africa Immunology Drug Market Share by Application in 2019 Figure 109. North America Immunology Drug Sales Growth Rate Forecast (2021-2026) (MT) Figure 110. North America Immunology Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 111. Europe Immunology Drug Sales Growth Rate Forecast (2021-2026) (MT) Figure 112. Europe Immunology Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 113. Asia Pacific Immunology Drug Sales Growth Rate Forecast (2021-2026) (MT) Figure 114. Asia Pacific Immunology Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 115. Latin America Immunology Drug Sales Growth Rate Forecast (2021-2026) (MT) Figure 116. Latin America Immunology Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 117. Middle East and Africa Immunology Drug Sales Growth Rate Forecast (2021-2026) (MT) Figure 118. Middle East and Africa Immunology Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 119. Porter's Five Forces Analysis Figure 120. Channels of Distribution Figure 121. Distributors Profiles Figure 122. Bottom-up and Top-down Approaches for This Report Figure 123. Data Triangulation Figure 124. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

New Pharmaceuticals and Healthcare Reports

Internal Neuromodulation Market Forecast 2025 | Global Report

Rising number of patients suffering from neurological disorders such as Parkinson’s, essential tremor, and primary dystonia is fueling the demand for internal neuromodulation procedures. Chronic back and leg pain associated with PVD (peripheral...

Gastrointestinal Cancer Treatment Market Size 2020-2025 | Growth Forecasts

As per credible projections, gastrointestinal cancer treatment industry is expected to register strong CAGR over 2019-2025. Rising adoption of unhealthy eating habits and increasing consumption of tobacco and alcohol have increased the pervasiveness ...

Topotecan Hydrochloride Market Trends and Research Insights by 2025

As per credible estimates, global topotecan hydrochloride market is poised to acquire commendable gains by the year 2025. Rising adoption of unhealthy and sedentary lifestyle has increased the pervasiveness of small cell lung cancer, ovarian cancer, ...

Flu Vaccine Market Share 2020-2025 | Global Industry Report

As per trusted estimates, global flu vaccine market will record substantial growth during 2020-2025. Increasing government initiatives to ensure the safety of the populace, minimal side-effects associated with influenza vaccines, improving efficacy o...

Healthcare Linen Market Size - Industry Trends Report 2025

According to reliable projections, global healthcare linen market is projected to record considerable growth during 2020-2025. Rising prevalence of various diseases including cardiovascular diseases, cancer, and arthritis along with increasing cases ...

Other Reports by QY Research

Global Noninvasive Cancer Diagnostics Market Size, Status and Forecast 2020-2026

Noninvasive Cancer Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Noninvasive Cancer Diagnostics market will be able to gain the upper hand as they use the report as a powerful...

Global Road Traffic Signs Market Insights and Forecast to 2026

Road Traffic Signs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Road Traffic Signs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental...

Global Traffic Safety System Market Size, Status and Forecast 2020-2026

Traffic Safety System market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Traffic Safety System market will be able to gain the upper hand as they use the report as a powerful resource. The seg...

Global Travel Technology Market Size, Status and Forecast 2020-2026

Travel Technology market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Travel Technology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental a...

Global Trailer Equipment Market Insights and Forecast to 2026

Trailer Equipment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Trailer Equipment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental a...

Publisher: QY Research
Chat with us